322 related articles for article (PubMed ID: 11362921)
41. Expert panel to update 'obsolete' guidelines.
AIDS Alert; 1995 Nov; 10(11):136. PubMed ID: 11362923
[TBL] [Abstract][Full Text] [Related]
42. New developments in antiretroviral drug therapy for HIV-1 infections.
Johnson VA
AIDS Clin Rev; 1995-1996; ():305-46. PubMed ID: 7488558
[No Abstract] [Full Text] [Related]
43. Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
Poscher M
AIDS Treat News; 1995 Jul; (no 227):2-4 concl. PubMed ID: 11362619
[TBL] [Abstract][Full Text] [Related]
44. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
Crowe S; Cooper DA; Chambers DE
Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
[TBL] [Abstract][Full Text] [Related]
45. Management of antiretroviral drug therapy in human immunodeficiency virus infection.
Stretcher B
Crit Rev Clin Lab Sci; 1994; 31(2):169-96. PubMed ID: 7917008
[TBL] [Abstract][Full Text] [Related]
46. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.
Hammer SM; Katzenstein DA; Hughes MD; Gundacker H; Schooley RT; Haubrich RH; Henry WK; Lederman MM; Phair JP; Niu M; Hirsch MS; Merigan TC
N Engl J Med; 1996 Oct; 335(15):1081-90. PubMed ID: 8813038
[TBL] [Abstract][Full Text] [Related]
47. AZT + 3TC: early results promising.
Colvin R; Haas G
Common Factor; 1995 Apr; (no 10):16. PubMed ID: 11362341
[TBL] [Abstract][Full Text] [Related]
48. New developments in antiretroviral drug therapy for HIV infection.
Johnson VA
AIDS Clin Rev; 1992; ():69-104. PubMed ID: 1318738
[No Abstract] [Full Text] [Related]
49. [Antiretroviral therapy. Current status and perspectives].
Lüthy R
Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
[No Abstract] [Full Text] [Related]
50. A closer look at 3TC. Interview by Mark Mascolini.
Rubin M
J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
[TBL] [Abstract][Full Text] [Related]
51. Protease inhibitors shine in triple combinations.
AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
[TBL] [Abstract][Full Text] [Related]
52. Triple combination superior to double combination.
Grodeck B
Posit Aware; 1995; ():6. PubMed ID: 11362210
[TBL] [Abstract][Full Text] [Related]
53. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.
Lancet; 1996 Aug; 348(9023):283-91. PubMed ID: 8709686
[TBL] [Abstract][Full Text] [Related]
54. Pediatric treatment update.
Grubman S
GMHC Treat Issues; 1996 Mar; 10(3):7-9. PubMed ID: 11363392
[TBL] [Abstract][Full Text] [Related]
55. Update on other antivirals.
Cheng B
PI Perspect; 1996 Apr; (no 18):7-8. PubMed ID: 11363513
[TBL] [Abstract][Full Text] [Related]
56. The role of didanosine in the management of HIV-1 infection.
Gazzard BG; Moyle GJ
Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
[TBL] [Abstract][Full Text] [Related]
57. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
58. New protease inhibitor studies.
Treat Rev; 1995 May; (no 18):2. PubMed ID: 11362591
[TBL] [Abstract][Full Text] [Related]
59. Three-drug combos.
Posit Aware; 1996; 7(1):6. PubMed ID: 11363125
[TBL] [Abstract][Full Text] [Related]
60. [Treatment by antiviral drugs of HIV-infected patients].
Mayaud C
Rev Pneumol Clin; 1993; 49(2):71-4. PubMed ID: 8272744
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
